Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV001091534 | SCV001247650 | pathogenic | not provided | 2025-03-01 | criteria provided, single submitter | clinical testing | ROGDI: PVS1, PM3:Strong, PM2 |
Institute of Human Genetics, |
RCV000034351 | SCV004242446 | pathogenic | Amelocerebrohypohidrotic syndrome | 2023-12-13 | criteria provided, single submitter | clinical testing | Criteria applied: PVS1,PM3,PM2_SUP |
Labcorp Genetics |
RCV000034351 | SCV004266545 | pathogenic | Amelocerebrohypohidrotic syndrome | 2024-09-09 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Glu170Argfs*72) in the ROGDI gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ROGDI are known to be pathogenic (PMID: 22424600, 23086778). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with Kohlschutter syndrome (PMID: 23086778). ClinVar contains an entry for this variant (Variation ID: 41465). For these reasons, this variant has been classified as Pathogenic. |
Gene |
RCV001091534 | SCV005325068 | pathogenic | not provided | 2023-11-13 | criteria provided, single submitter | clinical testing | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 28638151, 34939736, 3236364, 23086778) |
OMIM | RCV000034351 | SCV000058332 | pathogenic | Amelocerebrohypohidrotic syndrome | 2013-02-01 | no assertion criteria provided | literature only |